Autopsy report · NCT00943371
A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)
Cause of deathNo reason given
Life of this trial
- Registered 1 year 11 months after it had already started.
- Ran for about 1 year 9 months before it stopped.
- 28 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Merck Sharp & Dohme LLC
- Sponsor type
- Industry
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- MK6349; Comparator: Placebo to MK6349
- Participants
- 28
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.